Skip to content

A Novel Technology Involving Cell Signaling, the PI3K Pathway: SHIP1 and SHIP2 Inhibitors

Different classes of these SHIP inhibitory compounds are effective in murine models of diseases including cancer, diabetes, and Alzheimer's

Published: 1st April 2021
A Novel Technology Involving Cell Signaling, the PI3K Pathway: SHIP1 and SHIP2 Inhibitors
Source: k_e_n, https://stock.adobe.com/uk/279977715, stock.adobe.com
Patents
  • Multiple patents
IP Status
  • Patented
Seeking
  • Licensing
  • Development partner